Il existe 2+ publications pour ce produit.
L’anticorps anti-CDKN1B Monoclonal Souris est utilisé pour la détection de CDKN1B dans des échantillons de Humain. Il a été validé pour ELISA.
CDKN1B
Reactivité: Humain
WB, IHC, ELISA, IF
Hôte: Lapin
Monoclonal
1G2
unconjugated
Recombinant Antibody
Indications d'application
ELISA: 1/10000
Restrictions
For Research Use only
Format
Liquid
Buffer
Ascitic fluid containing 0.03 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Lee, Kim: "The function of p27 KIP1 during tumor development." dans: Experimental & molecular medicine, Vol. 41, Issue 11, pp. 765-71, (2009) (PubMed).
Duncan, Al-Attar, Rolland, Harper, Spendlove, Durrant: "Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer." dans: International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists, Vol. 29, Issue 1, pp. 8-18, (2009) (PubMed).
P27 KIP 1 is a cell cycle regulatory mitotic inhibitor of cdk activity. p27 KIP 1 is a candidate tumor suppressor gene, and has been proposed to function as a possible mediator of TGF beta induced G1 arrest. p27 KIP 1 is up regulated in response to antimitogenic stimuli. The increased protein expression of p27 results in cellular arrest by binding to cyclin/Cdk complexes such as cyclin D1/Cdk4. Decreased levels of p27Kip1, mainly due to proteosomal degradation, are found in various epithelial tumors originating from lung, breast, colon, ovary, esophagus, thyroid and prostate.Tissue specificity: Expressed in all tissues tested. Highest levels in skeletal muscle, lowest in liver and kidney.